바이오디펜스 시장 조사 - 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00005377
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 136
Buy Now

바이오디펜스 시장은 2019년 US$ 4,108.24 Mn에서 2027년 US$ 8,350.74 Mn에 이를 것으로 예상됩니다. 시장은 2020-2027년 CAGR 9.4%로 성장할 것으로 예상됩니다.< /h3>

생물방어는 생물학적 위협이나 전염병에 노출되어 있거나 노출될 수 있는 유기체 그룹의 차단방역을 복원하기 위해 취해진 조치를 말합니다. 이는 생물학적 위협에 대응하고 질병 확산을 제한하며 급증하는 의료 서비스를 제공하도록 설계된 강력한 질병 감시와 신속한 조치를 갖춘 효과적인 공공 의료 시스템입니다. 시장의 성장은 유리한 정부 이니셔티브의 존재, 자연 발생 발생 건수의 증가, 생물 무기 및 핵무장 ICBM의 위협 증가와 같은 몇 가지 주요 추진 요인에 기인합니다. 그러나 개발도상국과 저개발국 정부의 낮은 R&D 자금으로 인해 예측 기간 동안 바이오디펜스 시장의 성장이 제한될 것으로 예상됩니다.

수익성이 좋은 지역 바이오디펜스 시장



시장 통찰력

호의적인 정부 계획의 존재

< p>매년 정부는 생물테러 공격에 대비하기 위해 백신 연구개발에 막대한 비용을 지출하고 있습니다. 예를 들어, 2018년 미국 정부는 국가생물방어전략 및 이행계획, 국가안보전략, 국가방위전략, 국가대테러전략, 국가대살상무기전략(National Counter WMD Strategy)을 발표했는데, 모두 생물보안과 생물방어를 포함하고 있다. 또한 미국 정부는 글로벌 건강 보안 전략을 준비하고 있으며 자연적, 우발적, 의도적 생물학적 위협에 대한 예방, 탐지 및 대응을 포함하는 글로벌 건강 보안 어젠다의 2024 프레임워크 개발을 지원하고 있습니다.

인플루엔자 백신 및 건강 보안 강화는 행정 명령 13887, "국가 보안 및 공중 보건 증진을 위한 미국의 인플루엔자 백신 현대화"를 지원하는 예산입니다. 인플루엔자 백신 제조 인프라 및 혁신을 위해 보건복지부(HHS) 전반에 걸쳐 2020년 제정 수준에 비해 9,500만 달러 인상을 제공합니다. 개선된 백신, 치료제, 진단법의 고급 연구 및 개발; 국제적인 전염병 대비; 전국적으로 백신 보장 범위가 개선되었습니다. 예산은 또한 BioShield 프로그램과 전략적 국가 비축량을 통해 HHS 생물 방어 및 비상 대비 조달에 자금을 지원합니다. 여기에는 CDC의 글로벌 보건 보안 활동을 지원하기 위한 1억 7,500만 달러가 포함되어 있으며 이는 2020년 제정 수준에 비해 5,000만 달러 증가한 것입니다.

정부가 이러한 현재와 미래에 참여함에 따라 정책 활동, 기존 생물보안 및 생물방어 정책을 이해함으로써 생물방어 시장에서 활동하는 제약회사는 생물테러에 대비하고 확장할 수 있는 상당한 기회를 갖게 됩니다. 예를 들어, 항생제 개발업체인 Spero Therapeutics는 탄저병, 전염병, 멜리오이도증을 비롯한 생물학적 위협에 대한 약물의 효과를 평가하기 위해 경구용 카바페넴 계열 후보인 SPR994에 대해 생물의학첨단연구개발청(Biomedical Advanced Research and Development Authority)으로부터 연방 연구 자금 1,570만 달러를 받았습니다. 또한, 생의학 첨단 연구 개발 당국에는 5년에 걸쳐 최대 2,850만 달러의 추가 지원 조항도 포함되어 있으며, 약물 내성 박테리아로 인한 복잡 요로 감염에 대한 Spero의 SPR994 임상 개발도 지원할 것입니다.  전 세계 정부의 이니셔티브는 바이오디펜스 부문에 관련된 기업에 기회의 창을 열어줍니다.

제품 통찰력

제품별 바이오디펜스 시장 , 탄저병, 천연두, 보툴리누스 중독, 방사선/핵 등으로 분류됩니다. 2019년 탄저병 부문은 세계 바이오디펜스 시장에서 가장 큰 시장 점유율을 차지했습니다. 이 부문은 주로 BioShield Act, Biomedical Advanced Research and Development Authority(BARDA)와 같은 다양한 계획을 통해 탄저병에 대한 적절한 백신을 개발하고 비축하기 위해 다른 국가 정부의 자금 지원이 증가함에 따라 예측 기간 동안 계속 지배력을 유지할 것으로 예상됩니다. ) 및 화학 & 생물방어.

제품별 세계 생물방어 시장 – 2018 & 2027



전략적 통찰력

제품 출시 및 승인 전략은 기업이 전 세계적으로 입지를 확장하고 증가하는 수요를 충족합니다. 이 전략은 제품 포트폴리오를 확장하기 위해 시장 참여자들이 가장 일반적으로 채택합니다.

바이오디펜스 시장에서 활동하는 시장 참여자들은 고객 기반을 확대하기 위해 확장 전략을 채택합니다. 이를 통해 플레이어는 자신의 브랜드 이름을 전 세계적으로 유지할 수 있습니다. 예를 들어, 2017년 1월 Emergent BioSolutions Inc.는 독일의 Building 55에서 제조된 BioThrax(탄저균 흡착형)를 판매하기 위해 독일 연방 보건부의 승인을 받았습니다.

글로벌 바이오디펜스 시장 – 제품별

  • 탄저병
  • 소형두
  • 보툴리누스 중독
  • 방사선/핵
  • 기타
  • li>

생물방어 시장 – 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • < li>유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 스페인
    • 나머지 유럽
  • 아시아 태평양
    • 중국
    • 인도
    • 대한민국
    • 일본
    • 호주
    • 아시아 태평양 지역
  • 중동 및amp; 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • UAE
    • 중동 및 아프리카 나머지 지역
  • 남아메리카
    • 브라질
    • 아르헨티나
    • 남아메리카의 나머지 지역

회사 프로필

  • 바이에른 북유럽
  • Alnylam Pharmaceuticals, Inc.
  • SIGA Technologies
  • < li>Emergent BioSolutions Inc.
  • Cleveland Bio Labs
  • Dynavax Technologies
  • Elusys Therapeutics, Inc.
  • Soligenix
  • < li>Altimmune
  • Pluristem Therapeutics
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is biodefense?

Biodefense is referred to the measures taken to restore biosecurity of a group of organism that are, or may be, subject to biological threats or infectious diseases. It is an effective public health care system with strong disease surveillance and rapid actions designed to counter biological threats, to limit the spread of disease and provide surge medical care.

What are the driving factors for the bioresorbable medical materials market across the globe?

Driving factors such as presence of favorable government initiatives increase in the number of naturally occurring outbreaks, increasing threat of biological weapons and nuclear armed ICBM. Additionally, the future trend such as predictive analytics to reshape biodefense market is likely to increase the growth in the forecast period.

What is the regional analysis in terms of bioresorbable medical materials?

Global biodefense market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for biodefense. Biological threats occurring to humans, animals and environment are among the most serious issues faced by the US and its national community. As the biological threat continues to increase, the US is focused towards strengthening its capabilities and considering preparation for bio threats and bioterrorism as one of the critical aspects of national security. The federal government in the US coordinates programs, and sets up budgets so as to prevent, respond and take actions against biological disasters.

The List of Companies - Biodefense Market

  1. Bavarian Nordic
  2. Alnylam Pharmaceuticals, Inc.
  3. SIGA Technologies
  4. Emergent BioSolutions Inc.
  5. Cleveland Bio Labs
  6. Dynavax Technologies
  7. Elusys Therapeutics, Inc.
  8. Soligenix
  9. Altimmune
  10. Pluristem Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports